EWP
INSM icon

Elevation Wealth Partners’s Insmed INSM Stock Holding History

Elevation Wealth Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.96K Buy
61
+27
+79% +$3.18K ﹤0.01% 1018
2026
Q2 		$3.63K Buy
+34
New +$4.12K ﹤0.01% 1090

Other funds holding INSM

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

Elevation Wealth Partners's INSM Position: Q3 2026 in Review

Elevation Wealth Partners increased its Insmed (INSM) stake by 79% in Q3 2026, buying an estimated $3.18K and bringing the position to 61 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Elevation Wealth Partners first reported a position in INSM in Q2 2026 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Elevation Wealth Partners held 61 shares of Insmed worth $6.96K as of Q3 2026.
  • Elevation Wealth Partners bought 27 Insmed shares in Q3 2026, an estimated $3.18K.
  • Insmed made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1018 holding.
  • Elevation Wealth Partners first reported a position in Insmed in Q2 2026 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.